EFFECT OF ACUTE ADMINISTRATION OF FISH-OIL (OMEGA-3 MARINE TRIGLYCERIDE) ON GASTRIC-ULCERATION AND SECRETION INDUCED BY VARIOUS ULCEROGENIC AND NECROTIZING AGENTS IN RATS

被引:19
作者
ALHARBI, MM
ISLAM, MW
ALSHABANAH, OA
ALGHARABLY, NM
机构
[1] Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh, 11451
关键词
D O I
10.1016/0278-6915(95)00021-S
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The fish oil commercially known as Marine-25 (omega-3 marine triglyceride) is an eicosapentaenoic acid (EPA)-rich oil. It was investigated for its ability to inhibit gastric secretion and to protect the gastric mucosa against the injuries caused by pyloric ligation, non-steroidal anti-inflammatory drugs (NSAIDs-aspirin and indomethacin), reserpine, hypothermic restraint stress and necrotizing agents [0.6 Mu HCl0.2 Mu NaOH or 80% (v/v) aqueous ethanol]. The results showed that the fish oil, at a dose of 5 or 10 ml/kg body weight, provided significant protection in the various experimental models used. It produced a significant inhibition of gastric mucosal damage induced by pyloric ligation, NSAIDs, reserpine or hypothermic restraint ulcers. Fish oil also exerted a significant inhibitory action on gastric mucosal lesions produced by various necrotizing agents. Our findings show that fish oil rich in eicosapentaenoic acid possesses both antisecretory and antiulcerogenic effects.
引用
收藏
页码:553 / 558
页数:6
相关论文
共 34 条
[1]   COD LIVER OIL INHIBITS INDOMETHACIN INDUCED GASTROPATHY WITHOUT AFFECTING ITS BIOAVAILABILITY AND PHARMACOLOGICAL ACTIVITY [J].
ALMESHAL, MA ;
LUTFI, KM ;
TARIQ, M .
LIFE SCIENCES, 1991, 48 (14) :1401-1409
[2]  
ASLAN A, 1992, AM J GASTROENTEROL, V87, P432
[3]   MECHANISM OF ULCEROGENIC ACTIVITY OF INDOMETHACIN AND OXYPHENBUTAZONE [J].
BHARGAVA, KP ;
GUPTA, MB ;
TANGRI, KK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1973, 22 (02) :191-195
[4]  
CHIU PJS, 1984, ARZNEIMITTEL-FORSCH, V34-2, P783
[5]   A STUDY ON THE ETIOLOGY OF RESERPINE ULCERATION AND THE ANTIULCER ACTION OF SOLCOSERYL IN RAT STOMACH [J].
CHO, CH ;
OGLE, CW ;
DAI, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (11) :823-825
[6]   SALICYLATE DAMAGE TO GASTRIC MUCOSAL BARRIER [J].
DAVENPORT, HW .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (23) :1307-+
[7]  
EMPEY LR, 1989, GASTROENTEROLOGY, V96, pA682
[8]  
FAUST TW, 1989, GASTROENTEROLOGY, V95, pA123
[9]  
GALIL AAN, 1968, BRIT J PHARM CHEMOTH, V33, P1
[10]   EXPERIMENTAL GASTRIC-MUCOSAL INJURY - LABORATORY MODELS REVEAL MECHANISMS OF PATHOGENESIS AND NEW THERAPEUTIC STRATEGIES [J].
GLAVIN, GB ;
SZABO, S .
FASEB JOURNAL, 1992, 6 (03) :825-831